Thursday, January 18, 2018 9:31:26 PM
USRM's response was after the letter. As important RMAT would be, that is not the reason for the run up to .10. The company changed it's entire business model last year and the rise to at least .10 was based on elimination of toxic debt, creating income, growing the business, and teaming up with others to make up for business weaknesses that were there. I know this because I have been here since 3 days before the stock rose from .002 to .04. The rise from .10 to .17 can be attributed at least in part, to RMAT. Now we have Texas RTT as a work around of the FDA's RMAT, so if it doesn't happen, it is no longer a problem. Check out what they are doing for ED, COPD, knee replacements, cancer, shoulders, elbows... This is a $100 billion industry and USRM is leading the way.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM